Skip to main content
Caplight Logo









Advata

Advata

Private
Bellevue, WashingtonHealthcare & Life Scienceshttps://advata.com

Last Round

Series D

Jul 16, 2021

Total Funding Raised

$171M

Company Overview

Advata is a healthcare technology company that provides advanced data analytics software and SaaS solutions for revenue cycle management, clinical decision support, and operational efficiency.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Revenue Cycle, Business Intelligence, Workflow Automation, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

revenue cycle managementRCMhealthcare analyticspopulation healthhealthcare SaaSrobotic process automationRPApredictive analyticsclinical decision supporthealth techworkflow automationmedical AIaccounts receivable automationdata integrationAI in healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Advata Comparables

Compare Advata with similar companies based on industry and business-model similarity.

Advata comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AKASA
83%
Notable
79%
MedeAnalytics
79%

Advata Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 16, 2021
Series CDec 18, 2019
Series BMay 22, 2018
Series AApr 6, 2017

Advata Investors

Notable investors and investment history

Advata investors
InvestorRounds
Breyer CapitalSeries D
Kaiser Permanente VenturesSeries D
7wire VenturesSeries B, Series C, Series A, Series D
Scale Venture PartnersSeries D, Series C
General CatalystSeries B, Series C, Series D, Series A
D1 Capital PartnersSeries D
Polaris PartnersSeries C, Series D, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 18, 2019

    $50M round led by Scale Venture Partners.

  • Apr 6, 2017

    $15M round led by General Catalyst.

Advata Filings

Explore SEC and related filing metadata, where available.

Advata filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Advata's valuation, stock price, and market status.

Is Advata a public or private company?

Advata is a private company.

What is the current stock price of Advata?

Advata is a private company with no public stock price. No recent secondary market data is available.

How much is Advata worth (valuation)?

Valuation information for Advata is not publicly available.

Can I buy Advata stock?

Advata shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Advata's last funding round?

Advata's most recent funding round was Series D on July 16, 2021.

Who are the main investors in Advata?

Key investors in Advata include Breyer Capital, Kaiser Permanente Ventures, Scale Venture Partners, General Catalyst, D1 Capital Partners.

Will Advata IPO soon?

No public IPO plans have been announced for Advata.

How can I track Advata secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Advata's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBellevue, Washington
Employee Range17
Year Founded2015
Last FundingJul 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?